NDC 69968-0731-01 - Neosporin Plus Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69968-0731
- Requested NDC
- 69968-0731-01
- Package NDCs from labels
- 69968-0731-1, 69968-0731-2, 69968-0731-01
- Manufacturer
- Kenvue Brands LLC
- Effective date
- 2025-11-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neosporin Plus Lidocaine - Kenvue Brands LLC | Kenvue Brands LLC | 2025-11-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69968-0731-1 | Neosporin Plus Lidocaine | 14.2 g in 1 TUBE | OINTMENT | 14.2 | 7 | |
| 69968-0731-1 | Neosporin Plus Lidocaine | 1 in 1 CARTON | OINTMENT | 1 | 7 | |
| 69968-0731-2 | Neosporin Plus Lidocaine | 1 in 1 CARTON | OINTMENT | 1 | 7 | |
| 69968-0731-2 | Neosporin Plus Lidocaine | 28.3 g in 1 TUBE | OINTMENT | 28.3 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69968-0731 | NEOSPORIN PLUS LIDOCAINE (BACITRACIN, NEOMYCIN, POLYMYXIN B, LIDOCAINE) OINTMENT [KENVUE BRANDS LLC] | 6 | Current NDC, 4 package rows | 20241120_e450b6a1-a8da-e5db-e053-2995a90a0ef0.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC | A-S Medication Solutions | c895676f-446a-4a93-a3d2-addcce96b108 | 2023-01-23 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| LIDODERM | LIDOCAINE PATCH 5% | TPU Pharma, Inc. | db0092f5-02a0-4076-ac32-969f075a6ab1 | 2022-12-02 | Warnings, Adverse reactions | 98PI200987 |
| Polymyxin B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 72dd6de6-31d6-4a8f-881b-91af91ed9314 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| lidocaine | LIDOCAINE | Proficient Rx LP | 8a85ea77-91ad-4222-9bfe-2ffaf73182e8 | 2022-11-01 | Warnings, Adverse reactions | 98PI200987 |
| Neomycin Sulfate | NEOMYCIN SULFATE | Teva Pharmaceuticals USA, Inc. | 777dbfab-f83e-4738-ae1e-78619a9f82a7 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| Lidocaine | LIDOCAINE | Asclemed USA, Inc. | 80dadfb5-cbe6-475f-9980-a1b255982753 | 2022-10-12 | Warnings, Adverse reactions | 98PI200987 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Proficient Rx LP | 548089f3-29d8-4ba8-af21-9e04356ac29c | 2022-10-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | f5ef71ae-fca9-4a57-ae88-f2b2d195a179 | 2022-08-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| BHI Skin | BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR | MediNatura Inc | 70ab2931-bd2d-43de-bb36-d019f78e3d73 | 2022-07-07 | Warnings | 4T6H12BN9U |
| REFRESH P.M. | MINERAL OIL, PETROLATUM | Allergan, Inc. | 24365d64-cd94-41cc-a7e1-033102d98114 | 2022-06-30 | Warnings | 4T6H12BN9U |
| Blockaid | LIDOCAINE, TETRACAINE | SofTap Inc | de3af3fa-8acf-2379-e053-2995a90ac77d | 2022-05-06 | Warnings | 98PI200987 |
| Minnerva II | LIDOCAINE, EPINEPHRINE | SofTap Inc | ddd34237-7770-19b3-e053-2995a90af775 | 2022-05-05 | Warnings | 98PI200987 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 98042cef-2839-49d6-a7bd-a1d29c74430b | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 601cab21-c211-4c34-be7b-f4fdd97a921a | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| lidocaine | LIDOCAINE | Proficient Rx LP | f9b290d2-0e24-4ca8-bca2-3016f5c404df | 2022-05-01 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Actavis Pharma, Inc. | 4d04052c-3e0a-469a-9265-99604f13e507 | 2022-04-30 | Warnings, Adverse reactions | 98PI200987 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | 2022-04-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM | Proficient Rx LP | 1252b997-3a81-4f3c-90e4-92f29ba15713 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Lidocaine | LIDOCAINE | Proficient Rx LP | 2c396307-cf12-41d0-89e6-0f4ec74df55e | 2022-04-01 | Warnings, Adverse reactions | 98PI200987 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | Proficient Rx LP | d1f55327-156f-44cd-b0fc-b1a938e8aa73 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.